First- and second-line treatment of non-small-cell lung cancer patients withEGFRmutation-positive tumors

2012 ◽  
Vol 1 (3) ◽  
pp. 201-217
Author(s):  
Martin Reck ◽  
Niels Reinmuth ◽  
David F Heigener
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

2007 ◽  
Vol 22 (3) ◽  
pp. 178 ◽  
Author(s):  
Yoon Ho Ko ◽  
Myung Ah Lee ◽  
Yeong Seon Hong ◽  
Kyung Shik Lee ◽  
Hyun Jin Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients

Lung Cancer ◽  
2007 ◽  
Vol 55 (1) ◽  
pp. 109-113 ◽  
Author(s):  
Alexander Schmittel ◽  
Maren Knödler ◽  
Patricia Hortig ◽  
Karsten Schulze ◽  
Eckhard Thiel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trial

2019 ◽  
Vol 8 (S2) ◽  
pp. S145-S148 ◽  
Author(s):  
Danilo Rocco ◽  
Luigi Della Gravara ◽  
Umberto Malapelle ◽  
Giancarlo Troncone ◽  
Cesare Gridelli
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document